Scholars Central

Editor

Fei Ye

Department of Pathology, Mount Sinai School of Medicine, USA

About

As published by the journal they serve.

Dr. Ye’s presently working in the department of Pathology, Mount Sinai School of Mediicne, USA. Research work had been focus on plant-derived agents and their anti-cancer activity and their molecular mechanism since 1995.

Research interests

  • SBX
  • can inhibit NSCLC cell growth in vitro and in animals
  • and SBX directly targets the ERK pathway. More significantly
  • SBX is more potent and much tolerable than carboplatin
  • apoptosis
  • angiogenesis
  • invasion and metastasis. Using this technology
  • Dr. Ye and her group identified several promising protein biomarkers for cancer diagnosis
  • molecular staging and prognosis

Journals they serve

The seats these journals name them in.

Articles we hold

Articles in the journals they serve whose byline carries this name.

This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.